The purpose of the study is to evaluate of the relationships between fractionated exhaled nitric oxide, disease activity, and symptom severity in patients with eosinophilic esophagitis compared to those without eosinophilic esophagitis.
Study Type
OBSERVATIONAL
Enrollment
80
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Fractionated exhaled nitric oxide (FeNO) level
The FeNO measurement will be performed using a hand-held analyzer, the NIOX MINO (Aerocrine, Sweden). During this non-invasive procedure the patient is asked to perform a 4-6 second single-breath exhalation into the NIOX MINO, which measures FeNO in 100s with an electrochemical sensor.
Time frame: baseline (day of first endoscopy)
Fractionated exhaled nitric oxide (FeNO) level
The FeNO measurement will be performed using a hand-held analyzer, the NIOX MINO (Aerocrine, Sweden). During this non-invasive procedure the patient is asked to perform a 4-6 second single-breath exhalation into the NIOX MINO, which measures FeNO in 100s with an electrochemical sensor.
Time frame: at about 4-12 weeks (day of second endoscopy)
Esophageal eosinophil counts as assessed by biopsy
Time frame: baseline (day of first endoscopy)
Esophageal eosinophil counts as assessed by biopsy
Time frame: at about 4-12 weeks (day of second endoscopy)
Serum eosinophil counts as assessed by complete blood count (CBC)
Time frame: baseline (day of first endoscopy)
Disease-related symptoms severity as assessed by Pediatric Eosinophilic Esophagitis Symptom Severity (PEESS) version 2.0 questionnaire
The range of total score is 0 to 100, with a higher score being indicative of more frequent and/or severe symptoms.
Time frame: baseline (day of first endoscopy)
Disease-related symptoms severity as assessed by Pediatric Eosinophilic Esophagitis Symptom Severity (PEESS) version 2.0 questionnaire
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The range of total score is 0 to 100, with a higher score being indicative of more frequent and/or severe symptoms.
Time frame: at about 4-12 weeks (day of second endoscopy)